Plan to attend the third
Ottawa, Ontario
Please join us in at the Westin Ottawa, Ontario as we host the third Canadian Symposium on Lysosomal Diseases (CSLD). We invite Physicians, Researchers, Registered Nurses, Genetic Counsellors and Trainees to attend this in-person Symposium.
The theme for this meeting is
Canadian and international leaders and experts will present innovative trends and solution-focused best practices in the diagnosis and management of lysosomal diseases.
We look forward to welcoming you to Ottawa!
11 Colonel By Drive, Ottawa, Ontario
The Westin Ottawa is ideally suited to host the 3rd Canadian Symposium on Lysosomal Diseases. It offers excellent meeting facilities and audiovisual services. Its central location features modern, well-equipped accommodation; easy access to shops, sites, restaurants and attractions; and a breathtaking view of the Parliament Buildings.
CSLD Organizers have secured a preferred group rate of $299 per night + applicable taxes for single/double rooms available until Tuesday, 17 September, 2024.
You may also reserve your accommodation now by calling the hotel reservation line:
1-613-560-7000 and referencing that you are attending the Symposium and use the code CSLD.
All fees are stated in Canadian dollars (CAD).
*Upon arrival at the Symposium, students may be asked for ID verifying student status.
There is limited funding available to students, trainees, nurses, genetic counsellors and others. Funding requests are subject to approval and receipts for all expenses will be required. Preference will be given to individuals who are presenting papers.
The deadline for submitting a bursary request is 30 June, 2024. Requests may be sent by email to and you should state the rationale for receiving a bursary in a short statement (max 250 words). Recipients will be notified on or before 3 September, 2024.
Credit Card
Wire Transfer
E-Transfer details will appear on the invoice.
All bank charges will be paid by the participant.
Cancellations received in writing prior to 10 July, 2024 will be charged a $25 administrative fee. Cancellations received after this date will not be refunded. Substitutions will be accepted with a request received in writing from the registered participant. Cancellations and substitutions should be forwarded to the CSLD Secretariat at .
CSLD 2024 offers an unprecedented opportunity to advocate for your organization by partnering with us. Investment impact for your organization at CSLD 2024 includes but is not limited to:
All fees are stated in Canadian dollars (CAD).
To confirm your commitment or learn more about opportunities to support CSLD 2024, please contact .
If you wish to submit an interesting case for consideration by the Scientific Review Committee, please email , making the subject line: CSLD Case for consideration and include a brief 200‑word description.
Your email should be text‑only; please do not include attachments.
The Third Canadian Symposium on Lysosomal Diseases (CSLD) will be held 18 – 19 October, 2024 at The Westin Ottawa, Ottawa, Ontario. The theme for this meeting is Lysosomal Diseases Over a Lifetime. It is anticipated this national event will bring together close to 100 physicians, scientists, researchers, clinicians, students and other health sector stakeholders who share an interest in the specialty of lysosomal diseases.
CSLD will be a fully in-person symposium.
Authors who wish to give a presentation should submit an abstract adhering to the following instructions:
The text of the abstract should be single-spaced and not exceed 250 words. Symposium participants rely heavily on the title and abstract to identify papers and posters of special interest. Please take great care in constructing both. Should your submission be accepted, this overview may be used on the CSLD website for promotion purposes. Do not include any author information in the body of your abstract.
Oral presentations will range from 10 to 30 minutes in length, including up to five minutes for questions. The length of the presentation will be determined by the Scientific Program Committee. Oral presentations will occur in person. Any requests for remote presentations will only be considered under expectational circumstances and are subject to approval by the scientific committee.
Poster presentation dimensions are 4 x 4 feet and will be presented on a vertical poster board.
Presenters will be notified of the acceptance of their presentation on or before 26 June, 2024. If for unforeseen reasons a presentation must be cancelled, the presenter must contact the as soon as possible.
Submissions must be submitted electronically using the form (see button below).
Abstract must be submitted using the link below by midnight EDT, 24 May, 2024. Any questions may be directed to the CSLD Secretariat at .
Showcasing, collaborating and learning from each other and invited experts is a priority of the Symposium. The Symposium will maximize the engagement of participants, acknowledge individual and collective experiences and provide opportunities to learn from those experiences.
All submissions welcome.
Lysosomal diseases (LSDs) are a group of rare inherited metabolic disorders characterized by the dysfunction of lysosomes, cellular organelles responsible for breaking down various substances. In LSDs, there is a deficiency of specific enzymes within the lysosomes, leading to the accumulation of undigested materials inside the cells. This accumulation can cause damage to tissues and organs throughout the body.
There are more than 50 different types of LSDs, each associated with a specific enzyme deficiency and a unique set of symptoms. Examples of LSDs include Gaucher disease, Fabry disease, Niemann-Pick disease, and Pompe disease.
The Canadian Symposium on Lysosomal Diseases (CSLD Symposium) is an event focused on bringing together experts, researchers, clinicians, genetic counsellors, and other stakeholders to discuss the latest advancements, research findings, and treatment options related to lysosomal diseases. Attending the Canadian Symposium on Lysosomal Diseases can offer several benefits, including:
Education: Participants can gain insights into the current state of research and treatment options for lysosomal diseases. Experts in the field may present new findings, methodologies, and approaches to managing these rare disorders.
Networking: The Symposium provides an opportunity for professionals and individuals involved in the field of lysosomal diseases to connect with one another. Networking can foster collaboration, information sharing, and the development of new research initiatives.
Advocacy and Awareness: The Symposium may include discussions on advocacy efforts and raising awareness about lysosomal diseases. Increased awareness is crucial for fostering research, securing funding, and improving the overall understanding of these rare disorders.
Professional Development: Healthcare professionals, researchers, scientists, and other stakeholders attending the CSLD will advance their professional development, grow their knowledge and create collaborations that may be applied in their work to enhance patient care and outcomes.
If you are involved in the field of lysosomal diseases or have a personal or professional interest in these disorders, attending the CSLD Symposium could be a valuable opportunity to stay informed, connect with others in the field, and contribute to the ongoing efforts to improve the lives of individuals affected by LSDs.